Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma

Calumenin (CALU) has been reported to be associated with invasiveness and metastasis in some malignancies. However, in glioma, the role of CALU remains unclear.

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yang Ying, Wang Jin, Xu Shihai, Shi Fei, Shan Aijun
Format:	article
Langue:	EN
Publié:	De Gruyter 2021
Sujets:	calumenin glioma epithelial-mesenchymal transition Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Accès en ligne:	https://doaj.org/article/21eb1e3ee65e4d1a84cdc63bad777bb5
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:21eb1e3ee65e4d1a84cdc63bad777bb5
record_format	dspace
spelling	oai:doaj.org-article:21eb1e3ee65e4d1a84cdc63bad777bb52021-12-05T14:11:05ZCalumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma2081-693610.1515/tnsci-2021-0004https://doaj.org/article/21eb1e3ee65e4d1a84cdc63bad777bb52021-02-01T00:00:00Zhttps://doi.org/10.1515/tnsci-2021-0004https://doaj.org/toc/2081-6936Calumenin (CALU) has been reported to be associated with invasiveness and metastasis in some malignancies. However, in glioma, the role of CALU remains unclear.Yang YingWang JinXu ShihaiShi FeiShan AijunDe Gruyterarticlecalumeningliomaepithelial-mesenchymal transitionNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENTranslational Neuroscience, Vol 12, Iss 1, Pp 67-75 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	calumenin glioma epithelial-mesenchymal transition Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
spellingShingle	calumenin glioma epithelial-mesenchymal transition Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Yang Ying Wang Jin Xu Shihai Shi Fei Shan Aijun Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
description	Calumenin (CALU) has been reported to be associated with invasiveness and metastasis in some malignancies. However, in glioma, the role of CALU remains unclear.
format	article
author	Yang Ying Wang Jin Xu Shihai Shi Fei Shan Aijun
author_facet	Yang Ying Wang Jin Xu Shihai Shi Fei Shan Aijun
author_sort	Yang Ying
title	Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
title_short	Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
title_full	Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
title_fullStr	Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
title_full_unstemmed	Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
title_sort	calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
publisher	De Gruyter
publishDate	2021
url	https://doaj.org/article/21eb1e3ee65e4d1a84cdc63bad777bb5
work_keys_str_mv	AT yangying calumenincontributestoepithelialmesenchymaltransitionandpredictspoorsurvivalinglioma AT wangjin calumenincontributestoepithelialmesenchymaltransitionandpredictspoorsurvivalinglioma AT xushihai calumenincontributestoepithelialmesenchymaltransitionandpredictspoorsurvivalinglioma AT shifei calumenincontributestoepithelialmesenchymaltransitionandpredictspoorsurvivalinglioma AT shanaijun calumenincontributestoepithelialmesenchymaltransitionandpredictspoorsurvivalinglioma
_version_	1718371407820226560

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma

Documents similaires